TheProfitWatch

NRSN - NeuroSense Therapeutics Ltd. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.22 0.04 (3.28%) --- --- --- -0.01 (-0.82%) 0.02 (1.64%) 0.0 (0.0%) 0.0 (0.0%)

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Category: /stock/categories/na
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
1.26
RVol:

Events

Period Kind Movement Occurred At

Related News